Valliance Asset Management Ltd bought a new position in shares of YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,607,175 shares of the company’s stock, valued at approximately $2,571,000. YS Biopharma comprises approximately 4.6% of Valliance […]